Replay available

CT Private Equity Trust (LSE:CTPE) — Annual Results (2025): Manager update

Annual Results (2025): Manager update hosted by CT Private Equity Trust (LSE:CTPE) on Investor Meet Company, held 2026-03-31.

Tue, March 31, 2026 at 6:00 AMendedReplay
CT Private Equity Trust (LSE:CTPE) — Annual Results (2025): Manager update
Company
CT Private Equity Trust PLC (LSE:CTPE)
Date
Tue, Mar 31, 2026, 6:00 AM ET
Replay
Watch the replay on this page · 51 min

On 6ix: 6ix.com/event/ct-private-equity-trust-plc-ctpe-annual-results-2025-manager-update

Replay

Transcript

Automated transcript · Written by software from the replay's audio. It can mishear names and figures; the replay is the record.

0:01 Good morning, ladies and gentlemen. Welcome to the CT PRIVATE EQUITY TRUST Annual Results Presentation. Throughout today's recorded meeting, attendees will be in listen only mode. Questions are encouraged. Please simply type in your question at any time and press send. Before we begin, we'd like to submit the following poll, and I'm sure the company will be most grateful for your participation. I'd now like to hand over to Andrew Hamish. Good morning to you both.

0:25 Good morning, everybody. Thanks for joining this results presentation covering the period to the end of December twenty twenty five. I'm Hamish Mayer. I have with me Andrew Carnworth. As I think most of you know, I'm stepping down as as manager, retiring at the end of May. So this is actually gonna be the last investor meet company presentation of of this format. We do have an AGM in May, which I'll I'll also be at, but this will be the last of of this one. So we're going to basically divide this between myself and Andrew because you'll have to get used to listening to to him speaking in future instead of me.

1:13 So I'm just gonna take you through the the highlights of the annual results. And this is just a reminder of how distinguished we've been over the years. But just looking at, summary of the results for 2025. If you look at the right hand column of the the top table there, you can see that the NAV total return for 2025 is 4.7%, which is almost identical to the return that we made in 2024. So the... I think you could say that was a consistent return. It is disappointing. We did expect to be better than that for 2025 with probably a stronger fourth quarter. It didn't come through various reasons for that, which we will talk about. But obviously, the you know, there have been quite a number of external shocks both in 2025 and also now so far this year, which I think you're all aware of unless you've been living under a rock somewhere.

2:21 A couple of points to to highlight that the realization total was just over £80,000,000 in 2025. That was down on 2024, but, you know, still quite a respectable number. We started off with good momentum in... At the beginning of 2025. That was sort of dented by the imposition of various tariffs. And then things accelerated towards the end of the year, but it wasn't enough to sort of exceed what we'd achieved prior year. In terms of new investments, we had a pretty steady process of new investments at just over £60,000,000 for 2025, which is very similar to the 59,000,000 we did in 2024.

3:18 In terms of the final quarter of the year, the final quarter is often quite a big moving quarter because you essentially have two quarters worth of gains coming in one quarter. But in the end, we were up 3.2%. As I said, a bit less than I had originally expected, but not surprising when you consider the environment. Realizations and new investments in that quarter were approximately balanced. There's a slight surplus in realizations. We have a quarterly dividend of 7.10p, which will be paid at the end of April. Now the eagle eyed amongst you will notice that is different from the 7.01.

4:04 So we're at 7.1 instead of 7.01. And the reason for that is that that means that the the dividend will have increased this year. Now it would naturally have increased anyway if the NAV had gone up a bit more. So we've we've deliberately increased it slightly in order that you all get a small increase.

4:27 The the yield is still about 5%, so the share price has been a bit volatile. It did rally significantly earlier in the year. We got up to, you know, $5.90 or or or nearly at that level before as sort of rattled back along with most of our peers since the the end of February. Co investments are now 39% of the portfolio. That's not that much different from where we have been. I mean, it is gradually going up. And as we realize, you know, we have to put more money to work to keep it growing. That that is essentially a good sign if we're realizing co investments. That is generally a good thing.

5:15 I'm just gonna hand over to Andrew now who's gonna take you through some of the recent exits, you know, quite quickly before we get into more of the detail. Brilliant. Thanks, Hamish, and good morning, everyone. So there were 49 exits from portfolio companies in the year returning an average of 3.3 times cost, which is great. I'm just gonna touch on a couple of those. So firstly, amethyst radiotherapy. This was a top 10 holding, and it's a pan European provider of high quality and cost effective cancer care. The company proved very resilient throughout COVID, maintaining life saving treatment, and it was sold in August 2025 returning 1.8 times cost.

6:15 Our long standing investment partner, Inflection, then raised the largest continuation vehicle or multi asset continuation vehicle in Europe. That was to acquire four companies that were very high performing. They had achieved their investment plans, but Inflection thought there was an awful lot more to go for and wanted to provide the... Those companies with more capital and time to fulfill their growth plans. So that provided a a great exit to investors. The trust got back 6,400,000,

6:54 and we retain exposure to these high performing assets through inflection strategic parts.

7:05 Those of you who've been shareholders for a long time will remember Docmatics. So this is a software company that's used by r and d research scientists to improve collaboration within and between laboratories. Now we sold most of our holding back in,

7:33 sorry, back in 2021 for a fantastic return. And then in July last year, the remaining holding was bought by Siemens. So that brings the overall return to a brilliant 8.3 times money and nearly 80% IRR. I think what's quite interesting here was the rationale for Siemens acquisition was to buy Docmatics as a cornerstone of its AI strategy. So, obviously, AI needs data on which to to work, and Docmatics provides that structured data that they can use for AI. And then finally, on the on the exits, we had just very recently a partial exit of Cardo.

8:26 So this is a UK based company that provides repair and maintenance to social housing. It's grown very, very rapidly both organically and through m and a. And in February this year, 2026, we sold part of our stake in the company, 65%.

8:50 That 65 returned 5.3 times our total cost, and we retain exposure and further upside through this company. That transaction has provided further company to to the... Sorry, further capital to the company to continue its growth plans.

9:14 Okay. So just looking at the long term progression of NAV plus the cumulative dividends, you can see that we've been in a sort of slightly lower growth environment the last couple of years, but we are we are growing. And we would expect to get back to, you know, more typical growth rate, you know, quite soon. We have...

9:39 We still got this dividend yield 5%, which I mentioned before. This puts us into the category of AIC next generation dividend hero, which means that we've increased our dividend every year for more than ten years. To be an actual dividend hero, you have to do it every year for twenty years. So there's a few more years to go, but we're making progress on that.

10:05 This is the long term NAV total return, share price, total return chart for the whole twenty seven years of our history. And you can see it is, you know, massively outperformed the all share index, which is the dotted line at the bottom. Those of you who've been tuning into these webinars regularly will remember that I keep saying that these two lines, NAV total return and share price total return, you know, should converge. And actually on this chart, you can see quite a nice convergence. Unfortunately, some of that has broken down a bit in the last few weeks because of the sell off in the market. But the principle that they will converge, I think is a good one too.

10:51 You know, with a with a significant discount at the moment of 35%, just bear in mind, did get down to about 15% only a few weeks ago. So there is a, I think, quite a conspicuous opportunity there for those that are prepared to sort of wait a little bit. This is just another way of looking at the five year performance in terms of, you know, discrete years. So you can see that the last three years we've had sort of low to mid single digit returns, but prior to that, they were a lot higher. You know, we would expect to get back up into the sort of double digit plus returns at some point in the reasonably near future.

11:36 It's difficult to predict that precisely, but that is where we thought we might get to last year. But then the external events intervened and made that difficult to achieve, but hopefully, it will be possible this year. This is the outstanding undrawn commitments, which are basically EUR 170,000,000. This is... They've actually been decreasing as a as a percentage of NAV, perfectly comfortable level. So we just show that as a matter, of course, nothing to worry about there. In terms of debt, we've got... At the end of the year, we had net debt of just under 100,000,000. It's it's similar. It's it's about 95,000,000 today, And it's it's basically... It's coming down slightly.

12:28 We've got plenty of spare capacity in our revolving credit facility, which runs out until next February, and we will renew it in good time before that before that before we get into the New Year. I'm gonna hand back to Andrew who can talk about the new investments that we've made during the year. So we're selectively making new investments both in in funds and co investments, and those are just shown on the next couple of slides. And then we can dig into some of the more recent. So HG MERCURY five, this is the smallest fund of this high performing software specialist.

13:22 It's targeting mid market software and services companies across Europe and selectively in North America.

13:34 Kester Capital four is another fund, and it's backing a high performing emerging manager, Kester, who we've backed since they since they started, since inception across three funds and three co investments, two of which have been realized, providing very strong returns. The focus of the fund is on UK technology and life sciences companies within the lower mid market. Then a co investment. So this is a co investment in Vanda Research. Vanda is a specialist provider of research and proprietary data to clients, including hedge funds, asset managers, investment banks, and even central banks.

14:35 Our co investment is alongside FPE Capital who are a specialist software and services investor, again, an emerging manager we've backed since inception. And we came in to help fund a transformational acquisition of a company, Exante, in New York. Following the acquisition, which happened at the end of last year, Vanda is the clear leader in the rapidly growing positioning and flow data market. So what that is is it's information on where investors are are positioned, where the capital capital is positioned, how it's allocated, and how their behavior is changing and is likely to change to different, situations.

15:31 So quite an exciting opportunity, I think. It's already been uplifted.

15:40 And then, Axiom Equity two, again, another emerging manager we've backed since inception. Here, the focus is on mission critical software companies within The UK and Ireland. We backed Acxiom in their first fund, since when since when they've had a very strong partial exit of one company, which on its own has returned over 60% of the fund commitment. So off to a great start.

16:15 And finally, we made a co investment earlier this year. This is alongside Buckthorn, who's the lead manager on Cardo as well. And it is a consolidation of manufacturers of low voltage cable and accessories across Europe. Now that's a highly fragmented market unlike The US, and we think there's a great opportunity to consolidate that and drive up margins within it. The platform has completed its first acquisition, and there's a very strong pipeline of further acquisitions to come. And then very excitingly, we've got a very experienced management team who have come in to to lead this.

17:11 In terms of realizations, there's been a good flow of exits despite the uncertainty with momentum building over the second half of the year, as Hamish mentioned. I'm not gonna go into these, but you can see there's a good mix by sector and geography.

17:34 Continues into this year. And similarly, with the drawdowns, a good mix of different types of business across different sectors. Hamish, back to back to you. Yeah. So this is just the this is just the chart of the distributions distributions and and drawdowns.

18:03 You can see that there's obviously an element of cyclicality in this if you look at the way that the line fluctuates. We obviously have control over the... Complete control over the co investments. And, you know, we closely forecast the others, the drawdowns in the funds plus the realizations there. And, you know, we're we're normally balanced. And if there was temporarily out of balance, we either, you know, we'll we'll reduce our debt or we can draw down debt. It's the largest underlying holding, so I'll just ask Andrew to sort of pick up some of the the high points on the top 10 holdings. Sure. So as you can see, this attributes 24 of NAV.

18:51 This year, that's reduced down to sort of 22% following the receipt of 14,000,000 from Cardo as we talked about earlier. Again, really nicely diversified by sector, geography, and lead manager. And there's a real mix of companies here from quite technical companies like Polaris, everyone's favorite company. It's a software company that amongst other things enables the police to issue speeding tickets. Two, at the other end of things, you know, consumer brands like WeirdFish, which is growing very, very rapidly despite the quite difficult UK consumer market.

19:40 So a a real mix of of companies across sectors.

19:47 Okay. Let's just look at some of these other stats in the portfolio. So those of you who follow the company for a while will notice there haven't been a huge amount of change here. In terms of the geographical split, The UK remains the largest single territory for us at about 40%, followed by The US, and then everything else is basically spread across Continental Europe. In terms of the vintage year, you know, age of the the portfolio,

20:21 about 36% is over four years old and more than half over five... Over three years old. And the reason we put this in is because the typical investment thesis for a holding is based around four or perhaps a five year hold. So when you get to three or four years in, if things have gone according to plan, people are planning an exit. So this is a measure of our maturing stock, if you like.

20:49 So the short summary is that we've got plenty of things that are coming through for realization over the next couple of years. In terms of the valuation, valuation on a weighted average basis and an enterprise value to EBITDA basis is 10.3 times, which is not particularly high when you look at our peer group. And in terms of the debt, it's debt to EBITDA is 2.5 times, which is actually quite low. We're not the underlying companies are not particularly highly geared.

21:25 If we look at the split by sector, this hasn't changed very much. I mean, I think before we have talked about our exposure to information technology and health care. Taking these two sectors together, you know, broadly defined accounts for nearly half the portfolio. We are fine about that. I don't think we're particularly out of line with the rest of our our market. But, you know, there are strong secular trends in both of these areas. Obviously, we hear a lot about information technology and software in particular at the moment, and we have, you know, 20% of our portfolio or slightly less than 20% actually is in software.

22:13 And, you know, that is because that that is a, you know, strong growing segment of the economy. Most of you will be aware that, you know, there's a software application for just about everything these days, and it's it's penetrating further and further into the economy and we are, you know, we're benefiting from that. We're playing that. We've also got a number of more,

22:36 you know, traditional sectoral areas, industrials, consumers, a little bit of financials in the mix there. The whole point about this spread is that private equity is naturally a risky activity. The only reliable way to reduce that inherently high risk down to moderate levels is to run a well diversified portfolio, and that's exactly what we do. And that's what this sectoral split shows.

23:09 So basically, just to conclude before we go into the Q and A, the anticipated recovery in deal activity, which we had seen good signs of

23:24 in the middle of last year, has been slowed by geopolitical shocks. It obviously affects business confidence, which affects people's propensity to deal either in terms of speed or of, action or price that they're prepared to pay. Any reasonable person is going to pause and and take stock before committing, you know, some cases, hundreds of millions of of of pounds of investment. We obviously can't predict exactly how things are gonna develop from here. But what we do see is that despite everything, is consistent demand for high quality companies with resilient, business models.

24:12 It's not as though appetite evaporates completely. People are still interested.

24:18 And during 2025, where we did have that sort of big tariff shock earlier in the year, we still achieved 49 exits at a weighted average return of 3.3 times cost and an uplift over carrying value of 18%, which is quite respectable. The premium in the past has been a bit more than that, but not that much

24:39 more. We're seeing excellent deal flow both in funds and co investments. I mean, actually, in these quieter periods where there are some pressures, you can often find extremely well priced deals. And that is the case. We probably execute in terms of co investments about 10% of the sort of proper good quality deals that we appraise. We appraise well over 100 every year. And, you know, we we have, know, many, many opportunities in this. Like any investment manager, we spend our time choosing and selecting a very small number of a large flow of possibilities. The underlying performance of the portfolio is good.

25:25 Now this is important because this will come through in the performance of the NAV and ultimately share price, not necessarily immediately, but it will come through. So the revenue growth in 2025 was 17% and the EBITDA growth, the cash flow and profits growth is 24%. So that is likely to come through at some point in the NEV or it certainly will come through when people come to buy these companies, which they will in due course. So I think, you know, these characteristics mean that we are well positioned to face the current uncertainty. We've got a good balance sheet. We've got a well diversified portfolio, and those companies themselves are growing nicely.

26:16 And because of that, I am very confident that we are well positioned to deliver growth in capital and income for shareholders as we have done over the last twenty seven years.

26:33 So... And I'm extremely confident that Andrew will will take the record forward and do a good job. No pressure there, but that is that is what I think. So I think we can we can probably open up for for q and a now.

26:51 Lovely. Okay. Thanks, Hamish. Thanks, Andrew, for the insight and the update. My name is Peter Brown. I'm part of the investment trust team at Columbia Threadneedle. Thank you for your questions. We've had a few already put into the chat room. Please add them as we go along if you wish. We're trying to, answer all of them, in the session. The first question, quite complicated, but I'll start from the beginning. From your experience, are the loss ratios for single asset secondaries lower than co investment deals or regular individual buyout deals? And is it fair to assume that the upside capture is lower for the single asset secondary deals and the range of returns is narrower compared to the co investment deals and regular buyout deals?

27:29 I'm gonna ask Andrew to answer that one. Yeah. So this is this is a great question. Just to start, there there are different types of single asset secondary, but I think what the question is driving at is where the asset continues with the same lead manager. So what we would typically call a continuation vehicle.

27:56 And in those, yes, our assumption is is very much in line with the questioner. We don't yet have empirical evidence to support that, but we believe in a single asset CV, you know the company well. The lead manager knows the company well, so you know what you're buying. So the risk is intrinsically lower. You also have a relationship with management, which, again, reduces that risk. The flip side, the returns are a little bit lower than we would expect in a co investment or or single buyout deal. In that, there's a lot of scrutiny on pricing.

28:44 And, you know, as a result, you tend to pay fair price. You're not gonna get a a... An absolute bargain on it. So very much in line with the questioner's ideas. But just to finish that off, there are different types of single asset secondaries. If you're buying from a different manager, then the risk and the return can be much higher, and the drivers can be very different. You know, that could be a forced seller, for example.

29:16 Thank you. Please can you provide a breakdown of the organic versus inorganic revenue and EBITDA growth? Note that both were very impressive last year compared to other private equity trusts. Yes. We had we had a look at this. We think that the breakdown is about fifty fifty organic versus inorganic.

29:39 Now, obviously, it depends on the individual companies and the the inorganic is sort of skewed towards relatively small number of companies that are, you know, highly acquisitive. So we did actually mention one of those in the presentation, Cargo, which is... Has grown through m and a largely. I mean, it's underlying businesses are also growing, but a lot of growth has been m and a. You know, there's nothing wrong with that. It's actually a perfectly good thing, but that is roughly the split, fifty fifty.

30:14 Okay. Thank you. Next question. You mentioned software companies in the portfolio are valued at 13 times... 13.6 times EV EBITDA, significantly lower than the HD portfolio. What do you think are the key drivers to the big valuation differences?

30:33 Andrew, take that one. Yeah. So I think there are a number of drivers here. The first and sort of most obvious is size. So HG is mainly focused on the kind of upper mid market and even the the large or or mega buyouts, whereas our focus is on the lower mid market getting into the mid market.

30:58 The second thing is is investment style. So across our portfolio, we're backing multiple software specialists, which have different strategies. HGs is very much focused on star assets, and as a result, higher higher pricing. And then I guess the third thing, maybe as a Scottish accountant and a Scottish team, we're quite price sensitive. Yes. I reiterate that last point. We're very price sensitive.

31:34 Thank you. Talking of EBITDA, strong EBITDA growth in 2025, why is this not shown in better NAV growth? Is it due to increasing debt or multiple contraction?

31:48 Well, there's a number there's a number of reasons why the underlying growth wouldn't come through strictly into the NAV growth. You've got you've got changes in multiples across the portfolio. I mean, they haven't changed that much, but there has been a bit of downward pressure in some sectors. One or two specific companies where they, you know, the fundamentals are alright, but the the the multiples that we value that have gone down. I mean, there's one of them in the oil services industry, which has had pretty stable profits, but the multiple in which those profits are valued has gone down significantly. You've also got the reduction in realizations.

32:33 Now I mentioned that the realizations were on average at an 18% premium to the immediate carrying value. So obviously, the smaller your quantum of realizations, the the smaller the contribution is gonna be from that premium. And then, you know, you've you've also got various, you know, costs that are in... Innate in the structure. So we have to grow at a reasonable level, you know, to overcome, you know, the cost of doing business if you like. But, you know, as I've mentioned right at the beginning, we we had expected things to be a bit stronger this year and, you know, the underlying strength of the portfolio are there, and we think these will come through.

33:22 You know, exactly the timing of that does depend on lots of things that are out with our control. But I think shareholders should be, you know, confident that they've got exposure to, you know, a robust, you know, growing portfolio. You just have to look at the the the track record and look at the underlying fundamentals. These will come through and represent themselves in NAV in due course.

33:48 Thank you. Several of the write downs appear to be UK based companies. Is The UK market particularly challenged versus other markets investing across the world at present or just very company specific?

34:00 It's not particularly challenged. I mean, it is a big market for us. It's, you know, it's 41% of our portfolio. I mean, there there are a number of company specific things. Obviously, we've got quite a lot of, you know, co investments in The UK and the one or two of the the companies that have had setbacks, that that comes through there. I mean, it's probably worth noting that we do have quite a bit in health care, and it's fair to say that The UK environment for health care companies has been a bit more challenging than in the rest of Europe. There's quite a lot of change going in... Going on within the the NHS, which is ultimately the, you know, the customer often in the... In these companies and also, you know, the public sector generally.

34:55 So, I mean, we've got exposure through August equity and opposite health care funds and and both of them have been down a bit in this latest valuation. We think this will correct itself over time. I mean, these people are experts in these sectors and have very good records. So just because you get a bit of a write down now doesn't mean that the companies won't provide good returns in due course. Okey dokey. Please, could you explain to what extent the CT PRIVATE EQUITY TRUST has direct or indirect exposure to the unregulated lending, otherwise known as shadow banking sector?

35:43 Pretty limited. I mean, first of all, we don't actually invest in that sector. And secondly, the companies that we are backing who all have... Most of them have debt will get that debt either from banks or from specialist debt funds. These are not unregulated entities. You know, they're they're all regulated.

36:14 So we don't think we're, you know, we're not really exposed there. I mean, the the, you know, we're not directly exposed. I mean, there could be indirect exposure if there was to be a sort of, you know, series of, you know, bad debts in the in the shadow lending market that would inevitably have a sort of knock on effect across the rest of of the market. But I don't think we're particularly exposed. It's not it's not a part of the ecosystem that we come across very much at all.

36:51 Okay. You had up a little earlier slide on sector breakdown. Question is how much of the portfolio is in software companies, and where do these stand with regards to AI developments? And are there any portfolio companies that are directly engaged in AI? I'm gonna ask Andrew to answer this one. He's more clued up on AI than I am. Sure. So it's it's about 20% of the portfolio that's in in software. Obviously, private markets have seen a a big sell off in SaaS businesses. We think our portfolio is is relatively well positioned. Firstly, it's all been made alongside software specialists that really understand software and AI.

37:42 And then they and we have been looking at the risks and opportunities of of AI for a while. But I think most importantly, our focus has always been on sort of mission critical software, profitable companies, and those with proprietary knowledge or customer trust. And I think those are things that build real sort of barriers to entry. By contrast, we think AI is most likely to disrupt the sort of very large horizontal, nonsector specific, software companies. So it's something that we look at super carefully, and continue to monitor, but, we're not worried at the moment.

38:31 And I forget. Is there another part of the question that I haven't addressed? No. No. It's fine. It's a... How how engaged are they in AI? But I think you Oh, yes. Sorry. And and across the portfolio within software and the other sectors, all of our investment partners are looking at how they can use AI to optimize the the company. So there's an awful lot going on within AI to drive efficiencies across the portfolio. So it provides a real opportunity as well as the risk. And on the same theme theme, we have a question regarding the HD fund that you suggested earlier that we'd put some money to work to... With. What's your view on how HD are managing their impact of AI?

39:18 Yeah. I I think they're they're very well positioned. They've got a a very large team of specialists. They've got a large AI specific team. Again, they really understand software and AI. So I think they're well positioned to help their companies through this transformation that's happening at the moment.

39:43 Next question is about dividends. How confident are you on the sustainability of the dividend at current levels if the NAV growth achieved in the past two to three years continues for the next two to three years?

39:56 Yeah. I'm I'm very confident. I mean, first of all, I don't think the last two to three years NAV growth will prove to be typical. I think we should accelerate. But even if we didn't, we have set the dividend level at at a level that we are very confident we can maintain. I mean, it's top priority for us is to maintain the the dividend. So I think we can be very confident of that. Thank you. How are vintages raised during the market peaks, e d e g 2018 to 2021, performing in terms of IRR? And how are the higher entry valuations ultimately compressing or expanding returns?

40:47 Andrew, do you want to have a stab at this one?

40:50 Yeah. No. It's it's a good question. I think those investments made in that period, some of them would have been obviously made at higher prices. And I think that typically will lead to slightly longer hold periods to get the required return. And that's why we're always very much focused on investing across vintages, constantly investing and laying the the foundations for future growth. Thank you. And we have quite a few on share price and discount movements. I will try not to get you to repeat things, but we'll start with this. The share price is regularly quite volatile even within a trading day with movements up and down of a few percent. What do you put this down to?

41:45 Yeah. I mean, the shares are, you know, they're reasonably liquid, but they're not they're not hugely liquid. So if there is, you know, buying interest out with the norm, then it will move the price one way or the other. I mean, our brokers, the market makers try to make sure it doesn't have undue impact. I think when you look at our liquidity, the turnover compared to the size of the company, it's actually good compared to our peer group. In fact, our liquidity is greater than a number of the companies. Our daily liquidity is greater than a number of the companies that are significantly bigger than us, two to three times the size. But obviously, it would be good if it was more liquid. We went on quite a long term process of breaking down the sort of shareholder blocks that we started with many years ago and getting more wealth managers and platforms and having a more diverse shareholder base because that tends to that tends to lead to better liquidity.

42:52 So that is never, you know, that's never completed that process. It's ongoing challenge. I mean, there's some questions here about discount. So, I mean, the discount did narrow significantly earlier this year.

43:09 You know, part of that was genuine sort of demand people trying to increase their position for the long term. We also had one of our other investment trusts within our stable was reconstructed and the people that were in the savings plan had the option of reinvesting their money into other investment trusts within the Columbia thread needle stable. And we we received some of that interest. It's about £5,000,000 worth. And so that that that went in to buy shares into a reasonably tight market, and that was one of the reasons the price ran up. Now a lot of that appreciation, I think, would have would have stuck were it not for, you know, the sort of start of the Iran war.

43:59 And that basically meant that

44:05 investors in private equity investment trust went into a sort of risk off mode as opposed to a risk on mode. And when that happens, the discounts open out. And we have seen that across our peer group. Interestingly, our our discount even at this wider level is still not not as wide as a number of our peers. Historically, you know, we we have tended to have a a narrower discount than than our peers. At one point, we got we got up to about 15% discount. And, you know, when things settle down a bit, we should get back to that.

44:46 Would the trust have considered a discount management strategy for the company shares? Yeah. Well, we do actually... We do have that. I mean, it's not a it's not a mechanistic, you know, we'll buy back at a certain level because if you have, you know, a policy that the market can see elements within the market will game it and it will be a sort of zero zero sum game. So when when the discount does gap out, you know, one of the possibilities is is that we buy back our own shares and enhance the NAV. That decision,

45:26 you know, is taken considering a number of things, you know, who are we buying back the shares from? Is there a loose line of stock? Are we gonna clear that entire line of stock? There's no point in just buying back a bit of it and leaving the rest of it to sort of erode your price. We also have to consider the alternative use of that capital in terms of new investments. I mean, a buy a buyback does enhance NAV immediately, but it is a one off. You know, you don't get it year after year in the way that you you can't... You can get when you invest in a company which has held for several years. So we basically will... We stay in touch with the market. If there's loose stock about our brokers, we'll inform us of that.

46:17 We obviously take their advice as well. But if we if we see, you know, big lines of loose stock and we've got the capacity, then we can and we'll buy back. We haven't done a lot of buybacks, but we've done more than most in our sector with one or two conspicuous examples. Those of you who cover the sector will know that just buying back the shares is not a panacea. It doesn't, you know, there's very little evidence that lots of buybacks actually significantly reduce your discount in this asset class. Excellent. Thank you. There's been a couple of messages. Just wishing you very well in your retirement, Hamish, and thanking you for an excellent job over your twenty five odd years of management.

47:06 And then looking forward to Andrew taking over the reins. I'm sure he'll do an excellent job. But if I can just close there. Thank you for your questions, everybody. We did get to manage to... We managed to ask and answer them all. But I'll just leave you with some final comments from the team. We'll hand back to Mark. Thanks. Thanks, Peter. Thanks, everybody, for these, you know, these kind comments. It has been, you know, it's been a great run that I've had managing this investment trust. I think it is a great vehicle for people to gain exposure to private equity. If it's the only exposure you have to private equity, then I think you can sleep very soundly at night with it in your portfolio. So I'd encourage everybody to stick with it.

47:53 It is a long term investment asset class. You know, I've run this company for twenty seven years. If you look at the record, you can see the long term benefits of the compounding returns. Okay. We've had a couple of sort of quiet years, but these tend to be the exception rather than the rule. So the key thing is to stay involved, take advantage of the discounts when they widen out or when there are quieter spells in terms of NAV movement. We gain exposure or we have exposure through these shares to a very wide range of companies internationally where it's very difficult to gain that exposure through the public markets.

48:40 So I would commend everybody to do that.

48:45 I have a lot of my own capital in these shares. I'll continue to have it there. I'm very confident in the ability of the team I've built up over the years, which is now going to be headed by Andrew to take things forward. And I hope you, shareholders, give them as much support as as you've given me over the last twenty seven years. Those of you who are able to should come to the AGM, which is on

49:18 May 28, I think. That will actually be my last day of work. And so if you're there, you will be able to get some champagne, and I'm very happy to have a chat with you. I should say that I am actually staying on as a senior adviser to Columbia Threadneedle Investment. So Andrew will be able to call upon me if money needs any additional insight or advice. He probably won't, but it's there as a facility. So I think as we go further into 2026, hopefully, we'll get more clarity on the international situation. I mean, does look quite ominous at the moment.

50:05 But I would reiterate that this is a resilient portfolio. It's a carefully selected portfolio in terms of the underlying companies, their management, the management, the funds that we go into. And so I think if you look at the past, we've gone through lots of different challenges in the last twenty seven years. This company has come through them well. And without sounding overconfident, I'm sure that it will prove resilient going forward. Thank you very much for joining. And as I say, hopefully, see some of you at the AGM. That's very kind, Hamish, Andrew Peter. Thank you for updating investors, and good luck, Hamish, moving forward. Can I please ask investors not to close this session as we will now redirect those on the call to provide you with their feedback?

50:56 On behalf of the team from Columbia Threadneedle Productivity TRUST, thank you for your time this morning.

Follow CT Private Equity Trust PLC into a list and get an email when it puts out news.

Latest news releases

Companies on this call

Speakers

Hamish Mair

Fund Manager at CT PRIVATE EQUITY TRUST PLC

Andrew Carnwath

Director at CT PRIVATE EQUITY TRUST PLC

Peter Brown

Investment Trust Sales Manager at CT PRIVATE EQUITY TRUST PLC

More from CT Private Equity Trust PLC